IFNB1 and neoplasm: In turn, mutant p53 caused an attenuation of the IFN-β activation in the cancer cells themselves by upregulating SOCS1, a negative regulator of the IFN pathway, therefore alleviating a suppressing effect of IFN-β on tumor cell migration.